Insulin Withdrawal
Showing 1 - 25 of >10,000
Diabetes, Diabetes, Type 1, Type1diabetes Trial in Chula Vista (YG1699, Dapagliflozin)
Completed
- Diabetes
- +3 more
-
Chula Vista, CaliforniaProSciento, Inc
Jul 27, 2022
Type 1 Diabetes, Diabetic Ketoacidosis Trial in Hanover (Dapagliflozin, Placebo oral tablet, Stress)
Recruiting
- Type 1 Diabetes
- Diabetic Ketoacidosis
- Dapagliflozin
- +3 more
-
Hanover, Lower Saxony, GermanyKinder- und Jugendkrankenhaus AUF DER BULT
Aug 3, 2022
Transgender Persons Trial in San Antonio (Botnia Clamp, Withdrawal of Gender Affirming Hormone Therapy (GAHT))
Recruiting
- Transgender Persons
- Botnia Clamp
- Withdrawal of Gender Affirming Hormone Therapy (GAHT)
-
San Antonio, TexasBartter Clinical Research Unit, Audie L. Murphy VA Hospital, sTX
Jan 18, 2022
Topical Insulin in Neurotrophic Keratopathy After Diabetic
Not yet recruiting
- Corneal Ulcer
- +2 more
- rapid acting insulin
-
BaNHA, EgyptBenha University
Jul 2, 2023
Diabetes, Type 1 Trial in Saint Louis (Dapagliflozin 10 MG [Farxiga], Biosense Breath Ketone Analyzer)
Not yet recruiting
- Diabetes Mellitus, Type 1
- Dapagliflozin 10 MG [Farxiga]
- Biosense Breath Ketone Analyzer
-
Saint Louis, MissouriWashington University
Sep 12, 2022
Diabetes, Type 1 Trial in Warsaw (Phenofibrate, Placebo)
Recruiting
- Diabetes Mellitus, Type 1
- Phenofibrate
- Placebo
-
Warsaw, Mazowieckie, Poland
- +1 more
Jun 8, 2023
Obstructive Sleep Apnea, Pre-diabetes Trial (CPAP withdrawal)
Not yet recruiting
- Obstructive Sleep Apnea
- Pre-diabetes
- CPAP withdrawal
- (no location specified)
Sep 6, 2022
Diabetes Trial in Cairo (aerobic training , tobacco cessation and nutritional advices, tobacco cessation and nutritional
Recruiting
- Diabetes
- aerobic training , tobacco cessation and nutritional advices
- tobacco cessation and nutritional advices
-
Cairo, EgyptAlaa mohamed Naguib
Nov 21, 2022
SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation Trial (AVTX-801, Placebo)
Not yet recruiting
- SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation
- AVTX-801
- Placebo
- (no location specified)
Jan 12, 2023
Ferritin, Insulin Sensitivity, Blood Donation Trial in Toledo (Whole blood standard donation)
Recruiting
- Ferritin
- +2 more
- Whole blood standard donation
-
Toledo, SpainUniversity of Castilla-La Mancha (Exercise Physiology Lab)
Mar 30, 2023
Type 1 Diabetes Trial in La Jolla (Dapagliflozin 10 MG [Farxiga], REMD-477, Placebo)
Completed
- Type 1 Diabetes
- Dapagliflozin 10 MG [Farxiga]
- +2 more
-
La Jolla, CaliforniaUC San Diego Altman Clinical & Translational Research Institute
Jan 20, 2023
Diabetes, Type 1, Diabetes, Diabetes Complications Trial in Rochester (Insulin Deprivation in Type 1 Diabetic Patients)
Completed
- Diabetes Mellitus, Type 1
- +2 more
- Insulin Deprivation in Type 1 Diabetic Patients
-
Rochester, MinnesotaMayo Clinic in Rochester
Feb 2, 2022
Metabolic Syndrome Trial in Guadalajara (Celery Seed, Placebo)
Recruiting
- Metabolic Syndrome
- Celery Seed
- Placebo
-
Guadalajara, Jalisco, MexicoINSTITUTO DE TERAPÉUTICA EXPERIMENTAL Y CLÍNICA. Centro Universi
Sep 25, 2023
Type 1 Diabetes Trial in La Jolla (REMD-477, Placebo)
Recruiting
- Type 1 Diabetes
- REMD-477
- Placebo
-
La Jolla, CaliforniaUC San Diego Altman Clinical & Translational Research Institute
Sep 22, 2021
Diabetes, Type 2 Trial (Telemonitoring 1, Telemonitoring 2)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Telemonitoring 1
- Telemonitoring 2
- (no location specified)
Nov 14, 2023
Cystic Fibrosis-related Diabetes Trial in Cambridge, London, Manchester (CamAPS FX, Standard insulin therapy with CGM)
Not yet recruiting
- Cystic Fibrosis-related Diabetes
- CamAPS FX
- Standard insulin therapy with CGM
-
Cambridge, United Kingdom
- +3 more
Jan 3, 2023
Type 1 Diabetes Trial (CamAPS HX, Standard insulin pump therapy with CGM)
Not yet recruiting
- Type 1 Diabetes
- CamAPS HX
- Standard insulin pump therapy with CGM
- (no location specified)
Dec 7, 2022
Type 1 Diabetes Trial in Cambridge (CamAPS FX using faster insulin aspart, CamAPS FX using standard insulin aspart)
Active, not recruiting
- Type 1 Diabetes Mellitus
- CamAPS FX using faster insulin aspart
- CamAPS FX using standard insulin aspart
-
Cambridge, Cambridgeshire, United Kingdom
- +1 more
Nov 9, 2022
Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease Trial in New York (Diazoxide oral suspension, 1 mg per
Recruiting
- Hyperinsulinemia
- +3 more
- Diazoxide oral suspension, 1 mg per kg per dose
- +3 more
-
New York, New YorkColumbia University Irving Medical Center
Feb 6, 2023
Endogenous Cushing's Syndrome Trial in Worldwide (Levoketoconazole, Placebo)
Completed
- Endogenous Cushing's Syndrome
- Levoketoconazole
- Placebo
-
Los Angeles, California
- +44 more
Oct 13, 2022
Obstructive Sleep Apnea Trial in Baltimore (Propranolol Oral Tablet, Placebo Oral Tablet, CPAP)
Enrolling by invitation
- Obstructive Sleep Apnea
- Propranolol Oral Tablet
- +2 more
-
Baltimore, MarylandJohns Hopkins Bayview Medical Center
Mar 14, 2022
HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer Trial (Evexomostat)
Not yet recruiting
- HR+/HER2-negative Breast Cancer
- Metastatic Breast Cancer
- (no location specified)
Jul 7, 2022
Hypoglycemic Risk in Type 1 Diabetes
Not yet recruiting
- Type 1 Diabetes
- Hypoglycemia
- Mixed Meal Tolerance Test (MMTT)
- +2 more
-
Exeter, Devon, United KingdomRoyal Devon University Healthcare NHS Foundation Trust
Dec 19, 2022
Diabetes, Hypoglycemia Trial in Baton Rouge (hyperinsulinemic-hypoglycemic clamp, 13C-MRS procedure/Acetate infusion)
Recruiting
- Diabetes
- Hypoglycemia
- hyperinsulinemic-hypoglycemic clamp
- 13C-MRS procedure/Acetate infusion
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Aug 29, 2022